-transparent.png){kind=logo}
To establish a rat urinary bladder carcinogenesis model in vitro, primary rat bladder epithelial cells were grown in media containing 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT), the water-soluble metabolite of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide (FANFT), for 4 weeks followed by long-term (4-7 months) exposure to control medium, sodium saccharin (NaS), or urea. Another set of cultures were exposed to ANFT, NaS and urea simultaneously. Several phenotypic changes were observed in the chemically exposed cell cultures, namely differences in cell morphology, increased growth rate and the ability to grow on plastic instead of rat-tail collagen support. All of the chemically exposed cultures were anchorage independent except one of those treated with NaS. The ANFT-treated cells followed by control medium or urea and cells treated with ANFT, NaS and urea were tumorigenic when transplanted to nude mice, whereas NaS or ANFT followed by NaS treatment were not. The tumors were carcinomas and their epithelial differentiation was verified by strong positive staining for cytokeratin. These studies demonstrate the urothelial transforming capability of ANFT in cell culture without the necessity for a long exposure to a secondary chemical.
A M Mann, and
T Masui, and
F J Chlapowski, and
T Okamura, and
C D Borgeson, and
S M Cohen
April 1983,
Cancer research,
A M Mann, and
T Masui, and
F J Chlapowski, and
T Okamura, and
C D Borgeson, and
S M Cohen
January 1975,
Biochemical pharmacology,
A M Mann, and
T Masui, and
F J Chlapowski, and
T Okamura, and
C D Borgeson, and
S M Cohen
March 1989,
Journal of chromatography,
A M Mann, and
T Masui, and
F J Chlapowski, and
T Okamura, and
C D Borgeson, and
S M Cohen
April 1986,
Carcinogenesis,
A M Mann, and
T Masui, and
F J Chlapowski, and
T Okamura, and
C D Borgeson, and
S M Cohen
September 1980,
The Journal of laboratory and clinical medicine,
A M Mann, and
T Masui, and
F J Chlapowski, and
T Okamura, and
C D Borgeson, and
S M Cohen
December 1984,
Cancer research,
A M Mann, and
T Masui, and
F J Chlapowski, and
T Okamura, and
C D Borgeson, and
S M Cohen
March 1984,
Mutation research,
A M Mann, and
T Masui, and
F J Chlapowski, and
T Okamura, and
C D Borgeson, and
S M Cohen
May 1988,
Biomedical & environmental mass spectrometry,
A M Mann, and
T Masui, and
F J Chlapowski, and
T Okamura, and
C D Borgeson, and
S M Cohen
January 1982,
Carcinogenesis,
A M Mann, and
T Masui, and
F J Chlapowski, and
T Okamura, and
C D Borgeson, and
S M Cohen
November 1992,
Carcinogenesis,
